Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Alector Signs Global License Deal With Genentech For AL050

(RTTNews) - Alector Inc. (ALEC), a biopharmaceutical company, on Monday announced that it has entered into an exclusive global licensing agreement with Genentech for its AL050 program.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

More from Monday 5 October →